Tapio Luostarinen

8PUBLICATIONS
22CO-AUTHORS
Cancer diagnosisPredictive and prognostic markersPreventative health careHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Jun 01, 2022
Association of Chlamydia trachomatis infection with cervical atypia in adolescent women with short-term or long-term use of oral contraceptives: a longitudinal study in HPV vaccinated women.

Indira Adhikari, Tiina Eriksson, Katja Harjula

|May 17, 2022
Circulating free testosterone and risk of aggressive prostate cancer: Prospective and Mendelian randomisation analyses in international consortia.

Eleanor L Watts, Aurora Perez-Cornago, Georgina K Fensom

|Feb 12, 2022
Human papillomavirus vaccine efficacy against invasive, HPV-positive cancers: population-based follow-up of a cluster-randomised trial.

Matti Lehtinen, Camilla Lagheden, Tapio Luostarinen

|Jun 07, 2021
Human papillomavirus seroprevalence in pregnant women following gender-neutral and girls-only vaccination programs in Finland: A cross-sectional cohort analysis following a cluster randomized trial.

Penelope Gray, Hanna Kann, Ville N Pimenoff

|Feb 06, 2019
Occurrence of human papillomavirus (HPV) type replacement by sexual risk-taking behaviour group: Post-hoc analysis of a community randomized clinical trial up to 9 years after vaccination (IV).

Penelope Gray, Tapio Luostarinen, Simopekka Vänskä

|May 31, 2018
Gender-neutral vaccination provides improved control of human papillomavirus types 18/31/33/35 through herd immunity: Results of a community randomized trial (III).

Matti Lehtinen, Tapio Luostarinen, Simopekka Vänskä

Pageof 2

Frequent Collaborators

3 joint publications

Penelope Gray

2 joint publications

Matti Lehtinen

2 joint publications

Simopekka Vänskä

2 joint publications

Joakim Dillner